Manufacturers Life Insurance Company, The Inhibrx, Inc. Transaction History

Manufacturers Life Insurance Company, The

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$32.76 - $39.56 $42,129 - $50,874	1,286 Added 9.61%	14,673 $512,000
Q4 2023 Feb 13, 2024	SELL	$14.5 - $38.0 $4,074 - $10,678	-281 Reduced 2.06%	13,387 $508,000
Q3 2023 Nov 15, 2023	BUY	$15.75 - $26.31 $236 - $394	15 Added 0.11%	13,668 $250,000
Q2 2023 Aug 11, 2023	BUY	$16.96 - $27.82 $17,570 - $28,821	1,036 Added 8.21%	13,653 $354,000
Q4 2022 Aug 11, 2023	BUY	$20.18 - $33.33 $8,193 - $13,531	406 Added 3.32%	12,617 $310,000
Q4 2022 Feb 13, 2023	BUY	$20.18 - $33.33 $8,193 - $13,531	406 Added 3.32%	12,617 $310,000
Q3 2022 Aug 11, 2023	SELL	$11.58 - $24.73 $5,315 - $11,351	-459 Reduced 3.62%	12,211 $219,000
Q3 2022 Nov 03, 2022	SELL	$11.58 - $24.73 $5,315 - $11,351	-459 Reduced 3.62%	12,211 $219,000
Q2 2022 Aug 11, 2023	BUY	$8.52 - $25.26 $7,957 - $23,592	934 Added 7.96%	12,670 $143,000
Q2 2022 Aug 15, 2022	BUY	$8.52 - $25.26 $7,957 - $23,592	934 Added 7.96%	12,670 $144,000
Q1 2022 Aug 11, 2023	SELL	$19.89 - $43.18 $17,523 - $38,041	-881 Reduced 6.98%	11,736 $261,000
Q1 2022 May 20, 2022	SELL	$19.89 - $43.18 $56,507 - $122,674	-2,841 Reduced 19.49%	11,736 $261,000
Q4 2021 Feb 16, 2022	SELL	$26.75 - $46.02 $15,996 - $27,519	-598 Reduced 3.94%	14,577 $637,000
Q3 2021 Nov 12, 2021	SELL	$25.18 - $37.81 $35,226 - $52,896	-1,399 Reduced 8.44%	15,175 $505,000
Q2 2021 Aug 12, 2021	BUY	$14.69 - $27.52 $243,472 - $456,116	16,574 New	16,574 $456,000

25.3K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $617M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.